RxDoctor Payments Data

Haley Millender

Family · Augusta, GANPI 1912659582

Payments from drug & device makers

$741in general payments, 2019–2025

Across 42 payments — averaging $17.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$136
  • Daiichi Sankyo Inc.$132
  • Novartis$81
  • Biohaven Pharmaceutical Holding Company Ltd.$77
  • Organon$76
  • Boehringer Ingelheim$63
  • plus $177 from 7 others

What the payments were for

  • Food & beverage$741100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$741 in reported general payments places this provider in the 60th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$41,264
Medicare patients
129
Services billed
1,149

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide35$62,941
OzempicSemaglutide15$34,052
JardianceEmpagliflozin22$31,857
MounjaroTirzepatide14$15,705
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$13,159
EliquisApixaban13$10,716
Gabapentin62$1,323
SynthroidLevothyroxine Sodium20$1,115
Atorvastatin Calcium174$1,064
Ventolin HfaAlbuterol Sulfate15$839
Rosuvastatin Calcium57$832
Diclofenac Sodium18$757
Lisinopril99$678
Montelukast Sodium38$650
Omeprazole43$642

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$136$78,64649 claims
Novo NordiskOzempic$43$34,05215 claims
Boehringer IngelheimJardiance$63$31,85722 claims
AbbVieSynthroid$14$1,11520 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 6,258 family providers in Georgia.

Other family in Augusta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →